Lavage with Allicin in Combination with Vancomycin Inhibits Biofilm Formation by Staphylococcus epidermidis in a Rabbit Model of Prosthetic Joint Infection
Background and Aim The present anti-infection strategy for prosthetic joint infections (PJI) includes the use of antibiotics and surgical treatments, but the bacterial eradication rates are still low. One of the major challenges is the formation of biofilm causing poor bacterial eradication. Recently it has been reported that allicin (diallyl thiosulphinate), an antibacterial principle of garlic, can inhibit bacteria adherence and prevent biofilm formation in vitro. However, whether allicin could inhibit biofilm formation in vivo is unknown. The aim of this study was to investigate the effects of allicin on biofilm formation, and whether allicin could potentiate the bactericidal effect of vancomycin in a rabbit PJI model. Methods A sterile stainless-steel screw with a sterile ultra-high molecular weight polyethylene washer was inserted into the lateral femoral condyle of the right hind knee joint of rabbit, and 1 mL inoculum containing 104 colony-forming units of Staphylococcus epidermidis was inoculated into the knee joint (n = 32). Fourteen days later, rabbits randomly received one of the following 4 treatments using continuous lavages: normal saline, vancomycin (20 mcg/mL), allicin (4 mg/L), or allicin (4 mg/L) plus vancomycin (20 mcg/mL). Three days later, the washer surface biofilm formation was examined by scanning electron microscopy (SEM). The bacterial counts within the biofilm of implanted screws were determined by bacterial culture. Results The lowest number of viable bacterial counts of Staphylococcus epidermidis recovered from the biofilm was in the rabbits treated with allicin plus vancomycin (P<0.01 vs. all other groups). The biofilm formation was significantly reduced or undetectable by SEM in rabbits receiving allicin or allicin plus vancomycin. Conclusion Intra-articular allicincan inhibit biofilm formation and enhance the bactericidal effect of vancomycin on implant surface in vivo. Allicin in combination with vancomycin may be a useful anti-infection strategy for the treatment of PJI.
References
[1]
Barrett J, Losina E, Baron JA, Mahomed NN, Wright J, et al. (2005) Survival following total hip replacement. J Bone Joint Surg Am 87: 1965–1971. doi: 10.2106/jbjs.d.02440
[2]
Del PJL, Patel R (2009) Clinical practice. Infection associated with prosthetic joints. N Engl J Med 361: 787–794. doi: 10.1056/nejmcp0905029
[3]
Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, et al. (2009) Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res 467: 2606–2612. doi: 10.1007/s11999-009-0834-6
[4]
Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, et al. (2010) Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 468: 52–56. doi: 10.1007/s11999-009-1013-5
[5]
Iarikov D, Demian H, Rubin D, Alexander J, Nambiar S (2012) Choice and doses of antibacterial agents for cement spacers in treatment of prosthetic joint infections: review of published studies. Clin Infect Dis 55: 1474–1480. doi: 10.1093/cid/cis735
Bradbury T, Fehring TK, Taunton M, Hanssen A, Azzam K, et al. (2009) The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty 24: 101–104. doi: 10.1016/j.arth.2009.04.028
[8]
Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH (2009) Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res 467: 1732–1739. doi: 10.1007/s11999-009-0857-z
[9]
Odum SM, Fehring TK, Lombardi AV, Zmistowski BM, Brown NM, et al. (2011) Irrigation and debridement for periprosthetic infections: does the organism matter. J Arthroplasty 26: 114–118. doi: 10.1016/j.arth.2011.03.031
[10]
Parvizi J, Adeli B, Zmistowski B, Restrepo C, Greenwald AS (2012) Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am 94: e104. doi: 10.2106/jbjs.k.01417
[11]
Zmistowski B, Fedorka CJ, Sheehan E, Deirmengian G, Austin MS, et al. (2011) Prosthetic joint infection caused by gram-negative organisms. J Arthroplasty 26: 104–108. doi: 10.1016/j.arth.2011.03.044
[12]
Zimmerli W, Moser C (2012) Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol 65: 158–168. doi: 10.1111/j.1574-695x.2012.00938.x
[13]
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351: 1645–1654. doi: 10.1056/nejmra040181
[14]
Beswick AD, Elvers KT, Smith AJ, Gooberman-Hill R, Lovering A, et al. (2012) What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients. BMC Med 10: 18. doi: 10.1186/1741-7015-10-18
[15]
Gallo J, Kolar M, Novotny R, Rihakova P, Ticha V (2003) Pathogenesis of prosthesis-related infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147: 27–35. doi: 10.5507/bp.2003.004
[16]
Widmer AF (2001) New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 33 Suppl 2S94–106. doi: 10.1086/321863
[17]
del PJL, Patel R (2007) The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 82: 204–209. doi: 10.1038/sj.clpt.6100247
[18]
Yang L, Hu Y, Liu Y, Zhang J, Ulstrup J, et al. (2011) Distinct roles of extracellular polymeric substances in Pseudomonas aeruginosa biofilm development. Environ Microbiol 13: 1705–1717. doi: 10.1111/j.1462-2920.2011.02503.x
[19]
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318–1322. doi: 10.1126/science.284.5418.1318
[20]
Arciola CR, Montanaro L, Costerton JW (2011) New trends in diagnosis and control strategies for implant infections. Int J Artif Organs 34: 727–736. doi: 10.5301/ijao.2011.8784
[21]
Perez-Giraldo C, Cruz-Villalon G, Sanchez-Silos R, Martinez-Rubio R, Blanco MT, et al. (2003) In vitro activity of allicin against Staphylococcus epidermidis and influence of subinhibitory concentrations on biofilm formation. J Appl Microbiol 95: 709–711. doi: 10.1046/j.1365-2672.2003.02030.x
[22]
Cruz-Villalon G, Perez-Giraldo C (2011) Effect of allicin on the production of polysaccharide intercellular adhesin in Staphylococcus epidermidis. J Appl Microbiol 110: 723–728. doi: 10.1111/j.1365-2672.2010.04929.x
[23]
Otto M (2008) Staphylococcal biofilms. Curr Top Microbiol Immunol 322: 207–228. doi: 10.1007/978-3-540-75418-3_10
[24]
Malloy KM, Davis GA (2009) Summary of ASHP/IDSA/SIDP vancomycin monitoring recommendations: a focus on osteomyelitis. Orthopedics 32: 499. doi: 10.3928/01477447-20090527-18
[25]
Isiklar ZU, Darouiche RO, Landon GC, Beck T (1996) Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthop Relat Res : 184–189.
[26]
Patel JD, Ebert M, Ward R, Anderson JM (2007) Staphylococcus epidermidis biofilm formation: effects of biomaterial surface chemistry and serum proteins. J Biomed Mater Res A 80: 742–751. doi: 10.1002/jbm.a.31103
[27]
Craig MR, Poelstra KA, Sherrell JC, Kwon MS, Belzile EL, et al. (2005) A novel total knee arthroplasty infection model in rabbits. J Orthop Res 23: 1100–1104. doi: 10.1016/j.orthres.2005.03.007
[28]
Sampedro MF, Huddleston PM, Piper KE, Karau MJ, Dekutoski MB, et al. (2010) A biofilm approach to detect bacteria on removed spinal implants. Spine (Phila Pa 1976) 35: 1218–1224. doi: 10.1097/brs.0b013e3181c3b2f3
[29]
Fujimura S, Sato T, Kikuchi T, Zaini J, Gomi K, et al. (2009) Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilm-forming Staphylococcus aureus. J Orthop Sci 14: 658–661. doi: 10.1007/s00776-009-1366-3
[30]
Monds RD, O’Toole GA (2009) The developmental model of microbial biofilms: ten years of a paradigm up for review. Trends Microbiol 17: 73–87. doi: 10.1016/j.tim.2008.11.001
[31]
Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45: 999–1007. doi: 10.1128/aac.45.4.999-1007.2001
[32]
Shuman EK, Urquhart A, Malani PN (2012) Management and prevention of prosthetic joint infection. Infect Dis Clin North Am 26: 29–39. doi: 10.1016/j.idc.2011.09.011
[33]
Haerdi-Landerer MC, Habermacher J, Wenger B, Suter MM, et al. (2010) Slow release antibiotics for treatment of septic arthritis in large animals. Vet J 184: 14–20. doi: 10.1016/j.tvjl.2009.02.013
[34]
Parisien JS, Shaffer B (1992) Arthroscopic management of pyarthrosis. Clin Orthop Relat Res : 243–247.
[35]
Chaudhry H, Madden K, Bhandari M (2014) Cochrane in CORR (R): Joint lavage for osteoarthritis of the knee. Clin Orthop Relat Res 472: 22–27. doi: 10.1007/s11999-013-3333-8
[36]
Meijer MC, van Weeren PR, Rijkenhuizen AB (2000) Clinical experiences of treating septic arthritis in the equine by repeated joint lavage: a series of 39 cases. J Vet Med A Physiol Pathol Clin Med 47: 351–365. doi: 10.1046/j.1439-0442.2000.00290.x
[37]
Manadan AM, Block JA (2004) Daily needle aspiration versus surgical lavage for the treatment of bacterial septic arthritis in adults. Am J Ther 11: 412–415. doi: 10.1097/01.mph.0000087296.80768.1e
[38]
Dodwell ER (2013) Osteomyelitis and septic arthritis in children: current concepts. Curr Opin Pediatr 25: 58–63. doi: 10.1097/mop.0b013e32835c2b42
[39]
Vos LM, Huddleston SJJ, Stegenga B (2013) Lavage therapy versus nonsurgical therapy for the treatment of arthralgia of the temporomandibular joint: a systematic review of randomized controlled trials. J Orofac Pain 27: 171–179. doi: 10.11607/jop.1007
[40]
Lettin AW, Neil MJ, Citron ND, August A (1990) Excision arthroplasty for infected constrained total knee replacements. J Bone Joint Surg Br 72: 220–224.
[41]
Mella-Schmidt C, Steinbrink K (1989) Value of irrigation-suction drainage in the treatment of early infection of joint implants. Chirurg 60: 791–794.
[42]
Tsumura H, Ikeda S, Ono T, Itonaga I, Taira H, et al. (2005) Synovectomy, debridement, and continuous irrigation for infected total knee arthroplasty. Int Orthop 29: 113–116. doi: 10.1007/s00264-004-0626-2
[43]
Kirr R, Wiberg J, Hertlein H (2006) Clinical experience and results of using the V.A.C. instill therapy in infected hip- and knee prosthetics. Zentralbl Chir 131 Suppl 1S79–82.
[44]
Brown NM, Cipriano CA, Moric M, Sporer SM, Della VCJ (2012) Dilute betadine lavage before closure for the prevention of acute postoperative deep periprosthetic joint infection. J Arthroplasty 27: 27–30. doi: 10.1016/j.arth.2011.03.034
[45]
Bahrs C, Schnabel M, Frank T, Zapf C, Mutters R, et al. (2003) Lavage of contaminated surfaces: an in vitro evaluation of the effectiveness of different systems. J Surg Res 112: 26–30. doi: 10.1016/s0022-4804(03)00150-1
